secwatch.observer — SEC 8-K summary
======================================

Issuer:     PharmaCyte Biotech, Inc. (PMCB)
CIK:        0001157075
Form:       8-K
Filed at:   2023-08-04T23:59:59+00:00
Accession:  0001683168-23-005293
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Auditor Armanino LLP resigns due to exit from public audits; no disagreements
-----------------------------------------------------------------------------

- Armanino resigned effective upon new auditor appointment or filing of Q for Jan 31, 2024.
- Resignation solely due to Armanino's exit from public company audit services, not company-related.
- No disagreements on accounting principles or reportable events in FY 2022 and FY 2023.
- Company began process to engage a new independent auditor for FY ending April 30, 2024.
- Armanino's audit reports for recent fiscal years were unqualified.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1157075/000168316823005293/0001683168-23-005293-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1157075/000168316823005293/pharmacyte_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-23-005293

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer